Author: creacionmx

Rezolsta® (Darunavir/Cobicistat): First Boosted Protease Inhibitor Co-formulated with Cobicistat

NS5A Resistance: Clinical Implications and Treatment Possibilities

Mouse Models for Studies of In Vivo Functions of HIV-1 Nef

Drug Interactions with Cobicistat- or Ritonavir-Boosted Elvitegravir

HIV and HCV Therapies in 2016: Optimal Regimens

News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference

Modeling Combination HCV Prevention among HIV-infected Men Who Have Sex With Men and People Who Inject Drugs

HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review

Report from the International Conference on Viral Hepatitis – 2017

Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection